Skip to main content
Top
Published in: Endocrine 1/2014

01-09-2014 | Original Article

Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia

Authors: Henrik Falhammar, Helena Filipsson Nyström, Marja Thorén

Published in: Endocrine | Issue 1/2014

Login to get access

Abstract

To determine quality of life (QoL) in adult males with congenital adrenal hyperplasia (CAH). CAH males with 21-hydroxylase deficiency (n = 30), 19–67 years old, were compared with controls (n = 32). QoL was assessed using questionnaires on general living conditions and sexual issues, and the psychological well-being index (PGWB) form. Fewer CAH males than controls were students (3 vs. 25 %, P = 0.028) and more had blue-collar work (57 vs. 33 %, P = 0.023). Patients were less interested in sports (47 vs. 72 %, P = 0.034) and art/literature/film (10 vs. 47 %, P = 0.004). PGWB total score was 82.7 ± 13.7 versus 87.0 ± 11.1 (P = NS), but hydrocortisone/cortisone acetate treated scored lower than controls and prednisolone treated. Glucocorticoid over-treated had lower QoL than those with poor control (PGWB total score 77.1 ± 13.5 vs. 92.4 ± 11.1, P = 0.026) and controls (P = 0.025). Total PGWB score was positively correlated with adrenal androgens and steroid precursors. Subscale scores indicated that patients with late diagnosis were more depressive (12.1 ± 2.8 vs. 13.9 ± 1.4, P = 0.011) and had a lower self-control (11.3 ± 3.6 vs. 13.1 ± 1.0, P = 0.019) compared with controls. Sexual satisfaction was similar in spite of more patients being sexually inactive (27 vs. 6 %, P = 0.040). Adult CAH males differed from controls with respect to type of occupation and spare time interests but had similar QoL despite being less sexually active. Optimizing glucocorticoid therapy might further improve QoL. Some disadvantages found in patients diagnosed late will hopefully not be seen in patients diagnosed by neonatal screening, but this has yet to be studied.
Literature
1.
go back to reference A. Wedell, A. Thilen, E.M. Ritzen, B. Stengler, H. Luthman, Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J. Clin. Endocrinol. Metab. 78(5), 1145–1152 (1994)PubMed A. Wedell, A. Thilen, E.M. Ritzen, B. Stengler, H. Luthman, Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J. Clin. Endocrinol. Metab. 78(5), 1145–1152 (1994)PubMed
4.
go back to reference P.W. Speiser, R. Azziz, L.S. Baskin, L. Ghizzoni, T.W. Hensle, D.P. Merke, H.F. Meyer-Bahlburg, W.L. Miller, V.M. Montori, S.E. Oberfield, M. Ritzen, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(9), 4133–4160 (2010). doi:10.1210/jc.2009-2631 PubMedCentralPubMedCrossRef P.W. Speiser, R. Azziz, L.S. Baskin, L. Ghizzoni, T.W. Hensle, D.P. Merke, H.F. Meyer-Bahlburg, W.L. Miller, V.M. Montori, S.E. Oberfield, M. Ritzen, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(9), 4133–4160 (2010). doi:10.​1210/​jc.​2009-2631 PubMedCentralPubMedCrossRef
5.
go back to reference H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(1), 110–116 (2007). doi:10.1210/jc.2006-1350 PubMedCrossRef H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(1), 110–116 (2007). doi:10.​1210/​jc.​2006-1350 PubMedCrossRef
6.
go back to reference H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. J. 56(4), 601–608 (2009)PubMedCrossRef H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. J. 56(4), 601–608 (2009)PubMedCrossRef
7.
go back to reference H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285–293 (2011). doi:10.1530/EJE-10-0877 PubMedCrossRef H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285–293 (2011). doi:10.​1530/​EJE-10-0877 PubMedCrossRef
8.
go back to reference C.F. Mooij, J.M. Kroese, H.L. Claahsen-van der Grinten, C.J. Tack, A.R. Hermus, Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clin. Endocrinol. 73(2), 137–146 (2010). doi:10.1111/j.1365-2265.2009.03690.x C.F. Mooij, J.M. Kroese, H.L. Claahsen-van der Grinten, C.J. Tack, A.R. Hermus, Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clin. Endocrinol. 73(2), 137–146 (2010). doi:10.​1111/​j.​1365-2265.​2009.​03690.​x
9.
go back to reference W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, S. Hahner, T.S. Han, P.V. Carroll, G.S. Conway, D.A. Rees, R.H. Stimson, B.R. Walker, J.M. Connell, R.J. Ross, Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. 95(11), 5110–5121 (2010). doi:10.1210/jc.2010-0917 PubMedCentralPubMedCrossRef W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, S. Hahner, T.S. Han, P.V. Carroll, G.S. Conway, D.A. Rees, R.H. Stimson, B.R. Walker, J.M. Connell, R.J. Ross, Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. 95(11), 5110–5121 (2010). doi:10.​1210/​jc.​2010-0917 PubMedCentralPubMedCrossRef
10.
go back to reference T.S. Han, R.H. Stimson, D.A. Rees, N. Krone, D.S. Willis, G.S. Conway, W. Arlt, B.R. Walker, R.J. Ross, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia. Clin. Endocrinol. 78(2), 197–203 (2013). doi:10.1111/cen.12045 CrossRef T.S. Han, R.H. Stimson, D.A. Rees, N. Krone, D.S. Willis, G.S. Conway, W. Arlt, B.R. Walker, R.J. Ross, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia. Clin. Endocrinol. 78(2), 197–203 (2013). doi:10.​1111/​cen.​12045 CrossRef
11.
go back to reference I. Nermoen, I. Bronstad, K.J. Fougner, J. Svartberg, M. Oksnes, E.S. Husebye, K. Lovas, Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167(4), 507–516 (2012). doi:10.1530/EJE-12-0196 PubMedCrossRef I. Nermoen, I. Bronstad, K.J. Fougner, J. Svartberg, M. Oksnes, E.S. Husebye, K. Lovas, Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167(4), 507–516 (2012). doi:10.​1530/​EJE-12-0196 PubMedCrossRef
12.
go back to reference H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(12), 4643–4649 (2007). doi:10.1210/jc.2007-0744 PubMedCrossRef H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(12), 4643–4649 (2007). doi:10.​1210/​jc.​2007-0744 PubMedCrossRef
13.
go back to reference H. Falhammar, H. Filipsson Nystrom, A. Wedell, K. Brismar, M. Thoren, Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 168(3), 331–341 (2013). doi:10.1530/EJE-12-0865 PubMedCrossRef H. Falhammar, H. Filipsson Nystrom, A. Wedell, K. Brismar, M. Thoren, Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 168(3), 331–341 (2013). doi:10.​1530/​EJE-12-0865 PubMedCrossRef
15.
go back to reference L. Frisen, A. Nordenstrom, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Moller, A. Nordenskjold, Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J. Clin. Endocrinol. Metab. 94(9), 3432–3439 (2009). doi:10.1210/jc.2009-0636 PubMedCrossRef L. Frisen, A. Nordenstrom, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Moller, A. Nordenskjold, Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J. Clin. Endocrinol. Metab. 94(9), 3432–3439 (2009). doi:10.​1210/​jc.​2009-0636 PubMedCrossRef
16.
go back to reference I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453–459 (2010). doi:10.1530/EJE-10-0284 PubMedCrossRef I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453–459 (2010). doi:10.​1530/​EJE-10-0284 PubMedCrossRef
18.
go back to reference N. Reisch, S. Hahner, B. Bleicken, L. Flade, F. Pedrosa Gil, M. Loeffler, M. Ventz, A. Hinz, F. Beuschlein, B. Allolio, M. Reincke, M. Quinkler, Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin. Endocrinol. 74(2), 166–173 (2011). doi:10.1111/j.1365-2265.2010.03920.x CrossRef N. Reisch, S. Hahner, B. Bleicken, L. Flade, F. Pedrosa Gil, M. Loeffler, M. Ventz, A. Hinz, F. Beuschlein, B. Allolio, M. Reincke, M. Quinkler, Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin. Endocrinol. 74(2), 166–173 (2011). doi:10.​1111/​j.​1365-2265.​2010.​03920.​x CrossRef
19.
go back to reference U. Kuhnle, M. Bullinger, H.P. Schwarz, The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur. J. Pediatr. 154(9), 708–716 (1995)PubMedCrossRef U. Kuhnle, M. Bullinger, H.P. Schwarz, The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur. J. Pediatr. 154(9), 708–716 (1995)PubMedCrossRef
20.
go back to reference M.A. Malouf, A.G. Inman, A.G. Carr, J. Franco, L.M. Brooks, Health-related quality of life, mental health and psychotherapeutic considerations for women diagnosed with a disorder of sexual development: congenital adrenal hyperplasia. Int. J. Pediatr. Endocrinol. 2010, 253465 (2010). doi:10.1155/2010/253465 PubMedCentralPubMedCrossRef M.A. Malouf, A.G. Inman, A.G. Carr, J. Franco, L.M. Brooks, Health-related quality of life, mental health and psychotherapeutic considerations for women diagnosed with a disorder of sexual development: congenital adrenal hyperplasia. Int. J. Pediatr. Endocrinol. 2010, 253465 (2010). doi:10.​1155/​2010/​253465 PubMedCentralPubMedCrossRef
21.
go back to reference J. Jaaskelainen, R. Voutilainen, Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr. 89(2), 183–187 (2000)PubMedCrossRef J. Jaaskelainen, R. Voutilainen, Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr. 89(2), 183–187 (2000)PubMedCrossRef
22.
go back to reference A. Nordenskjold, G. Holmdahl, L. Frisen, H. Falhammar, H. Filipsson, M. Thoren, P.O. Janson, K. Hagenfeldt, Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 93(2), 380–386 (2008). doi:10.1210/jc.2007-0556 PubMedCrossRef A. Nordenskjold, G. Holmdahl, L. Frisen, H. Falhammar, H. Filipsson, M. Thoren, P.O. Janson, K. Hagenfeldt, Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 93(2), 380–386 (2008). doi:10.​1210/​jc.​2007-0556 PubMedCrossRef
23.
go back to reference A. Nordenstrom, L. Frisen, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Nordenskjold, Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients’ perception. J. Clin. Endocrinol. Metab. 95(8), 3633–3640 (2010). doi:10.1210/jc.2009-2639 PubMedCrossRef A. Nordenstrom, L. Frisen, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Nordenskjold, Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients’ perception. J. Clin. Endocrinol. Metab. 95(8), 3633–3640 (2010). doi:10.​1210/​jc.​2009-2639 PubMedCrossRef
24.
25.
go back to reference K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, L. Frisen, M. Thoren, A. Nordenskjold, Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod. 23(7), 1607–1613 (2008). doi:10.1093/humrep/den118 PubMedCrossRef K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, L. Frisen, M. Thoren, A. Nordenskjold, Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod. 23(7), 1607–1613 (2008). doi:10.​1093/​humrep/​den118 PubMedCrossRef
26.
27.
go back to reference H.J. Dupuy, The psychological general well-being (PGWB) index. Assessment of quality of life in clinical trials of cardiovascular therapies (Le Jacq Publishing Inc, New York, 1984) H.J. Dupuy, The psychological general well-being (PGWB) index. Assessment of quality of life in clinical trials of cardiovascular therapies (Le Jacq Publishing Inc, New York, 1984)
29.
go back to reference T.S. Han, N. Krone, D.S. Willis, G.S. Conway, S. Hahner, D.A. Rees, R.H. Stimson, B.R. Walker, W. Arlt, R.J. Ross, Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur. J. Endocrinol. 168(6), 887–893 (2013). doi:10.1530/EJE-13-0128 PubMedCentralPubMedCrossRef T.S. Han, N. Krone, D.S. Willis, G.S. Conway, S. Hahner, D.A. Rees, R.H. Stimson, B.R. Walker, W. Arlt, R.J. Ross, Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur. J. Endocrinol. 168(6), 887–893 (2013). doi:10.​1530/​EJE-13-0128 PubMedCentralPubMedCrossRef
30.
go back to reference B. Bleicken, M. Ventz, A. Hinz, M. Quinkler, Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period. Endocr. J. 59(10), 931–939 (2012)PubMedCrossRef B. Bleicken, M. Ventz, A. Hinz, M. Quinkler, Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period. Endocr. J. 59(10), 931–939 (2012)PubMedCrossRef
31.
go back to reference M. Hines, C. Brook, G.S. Conway, Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J. Sex Res. 41(1), 75–81 (2004). doi:10.1080/00224490409552215 PubMedCrossRef M. Hines, C. Brook, G.S. Conway, Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J. Sex Res. 41(1), 75–81 (2004). doi:10.​1080/​0022449040955221​5 PubMedCrossRef
Metadata
Title
Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia
Authors
Henrik Falhammar
Helena Filipsson Nyström
Marja Thorén
Publication date
01-09-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0161-2

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine